Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Kosice, 041 81 Kosice, Slovakia.
Institute of Parasitology, Slovak Academy of Sciences, 041 81 Kosice, Slovakia.
Cells. 2020 Dec 1;9(12):2571. doi: 10.3390/cells9122571.
The aim of this study was to investigate the use of a standardized animal model subjected to antibiotic treatment, and the effects of this treatment on the course of dextran sodium sulphate (DSS)-induced colitis in mice. By decontamination with selective antibiotics and observation of pathogenesis of ulcerative colitis (UC) induced chemically by exposure of mice to various concentrations of DSS, we obtained an optimum animal PGF model of acute UC manifested by mucin depletion, epithelial degeneration and necrosis, leading to the disappearance of epithelial cells, infiltration of and submucosa with neutrophils, cryptitis, and accompanied by decreased viability of intestinal microbiota, loss of body weight, dehydration, moderate rectal bleeding, and a decrease in the selected markers of cellular proliferation and apoptosis. The obtained PGF model did not exhibit changes that could contribute to inflammation by means of alteration of the metabolic status and the induced dysbiosis did not serve as a bearer of pathogenic microorganisms participating in development of ulcerative colitis. The inflammatory process was induced particularly by exposure to DSS and its toxic action on compactness and integrity of mucosal barrier in the large intestine. This offers new possibilities of the use of this animal model in studies with or without participation of pathogenic microbiota in IBD pathogenesis.
本研究旨在探讨使用经过抗生素处理的标准化动物模型,以及这种处理对小鼠葡聚糖硫酸钠(DSS)诱导结肠炎病程的影响。通过选择性抗生素去污和观察各种浓度 DSS 暴露诱导的小鼠溃疡性结肠炎(UC)发病机制,我们获得了一种最佳的急性 UC 动物 PGF 模型,其特征为粘蛋白耗竭、上皮变性和坏死,导致上皮细胞消失、中性粒细胞浸润和黏膜下、隐窝炎,并伴有肠道微生物群落活力下降、体重减轻、脱水、中度直肠出血以及细胞增殖和凋亡的选择标志物减少。所获得的 PGF 模型没有通过改变代谢状态而导致炎症变化,并且诱导的生态失调也不作为参与溃疡性结肠炎发展的致病微生物的载体。炎症过程是由 DSS 的暴露及其对大肠黏膜屏障致密性和完整性的毒性作用特别引起的。这为在有或没有致病微生物参与的 IBD 发病机制研究中使用这种动物模型提供了新的可能性。
J Crohns Colitis. 2016-11
Lab Anim Res. 2024-5-16
Gastroenterol Rep (Oxf). 2024-4-16
J Clin Med. 2019-10-9
Mediators Inflamm. 2019-5-28
Front Cell Infect Microbiol. 2019-4-24
Immunity. 2019-1-15